Prot #PTI-428-01: A Phase I/II, Multi-Center, Randomized, Placebo-Controlled, Study Designed to Assess the Safety, Tolerability, and Pharmacokinetics of PTI-428 in Subjects with Cystic Fibrosis

Project: Research project

Project Details

StatusFinished
Effective start/end date6/28/17 → 6/28/20

Funding

  • Quintiles, Inc. (Prot #PTI-428-01 // Prot #PTI-428-01)
  • Proteostasis Therapeutics, Inc. (Prot #PTI-428-01 // Prot #PTI-428-01)